Expression of interleukin-11 and interleukin-11 receptor α in human colorectal adenocarcinoma; Immunohistochemical analyses and correlation with clinicopathological factors

World Journal of Gastroenterology

Volumn 12, Issue 2, 2006, Pages 317-321

  Yamazumi, Kazuyuki ^a   Nakayama, Toshiyuki ^a   Kusaba, Takafumi ^a   Wen, Chun Yang ^b   Yoshizaki, Ayumi ^a   Yakata, Yuichi ^a   Nagayasu, Takeshi ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Colorectal cancer; IL 11; IL 11 receptor

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 11 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER INVASION; CELL DIFFERENTIATION; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPLASM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 33644784090     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i2.317     Document Type: Article

References (36)

1. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group. Cancer 1986; 58: 1340-1345
2. Baisse B, Bouzourene H, Saraga EP, Bosman FT, Benhattar J. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 2001; 93: 346-352
3. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-297
4. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665
5. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49-56
6. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217-221
7. Dix B, Robbins P, Carrello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994; 70: 585-590
8. Teramura M, Kobayashi S, Yoshinaga K, Iwabe K, Mizoguchi H. Effect of interleukin 11 on normal and pathological thrombopoiesis. Cancer Chemother Pharmacol 1996; 38 Suppl: S99-S102
9. Yang YC. Interleukin 11: an overview. Stem Cells 1993; 11: 474-486
10. Keller DC, Du XX, Srour EF, Hoffman R, Williams DA. Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 1993; 82: 1428-1435
11. Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994; 93: 1516-1524
12. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 1994; 12 Suppl 1: 79-89; discussion 89-90
13. Potten CS. Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer 1995; 62: 356-361
14. Orazi A, Du X, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996; 75: 33-42
15. Du X, Liu Q, Yang Z, Orazi A, Rescorla FJ, Grosfeld JL, Williams DA. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 1997; 272: G545-G552
16. Curtis DJ, Hilton DJ, Roberts B, Murray L, Nicola N, Begley CG. Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist. Blood 1997; 90: 4403-4412
17. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998; 334 (Pt2): 297-314
18. Campbell CL, Guardiani R, Ollari C, Nelson BE, Quesenberry PJ, Savarese TM. Interleukin-11 receptor expression in primary ovarian carcinomas. Gynecol Oncol 2001; 80: 121-127
19. Campbell CL, Jiang Z, Savarese DM, Savarese TM. Increased expression of the interleukin-11 receptor and evidence of 33 STAT3 activation in prostate carcinoma. Am J Pathol 2001; 158: 25-32
20. Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett 2001; 169: 87-95
21. Booth C, Potten CS. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 1995; 28: 581-594
22. Soda H, Raymond E, Sharma S, Lawrence R, Cerna C, Gomez L, Schaub R, Von Hoff DD, Izbicka E. Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors. Anticancer Drugs 1999; 10: 97-101
23. Jass JR, Sabin LH. Histological typing of intestinal tumors, World Health Organization International Histological Classification of Tumors (2nd ed). Berlin, Germany: Springer-Verlag, 1989
24. Greene FL, Page DL, Fleming ID (eds). Cancer staging handbook: From the American joint commit tee on cancer Cancer staging manual (6th ed) pp.127-129, New York, USA: Springer-Verlag, 2002
25. Campbell CL, Jiang Z, Savarese DM, Savarese TM. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 2001; 158: 25-32
26. Minshall E, Chakir J, Laviolette M, Molet S, Zhu Z, Olivenstein R, Elias JA, Hamid Q. IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 2000; 105: 232-238
27. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993; 268: 21527-21532
28. Morris JC, Neben S, Bennett F, Finnerty H, Long A, Beier DR, Kovacic S, McCoy JM, DiBlasio-Smith E, La Vallie ER, Caruso A, Calvetti J, Morris G, Weich N, Paul SR, Crosier PS, Turner KJ, Wood CR. Molecular cloning and characterization of murine interleukin-11. Exp Hematol 1996; 24: 1369-1376
29. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004; 23: 3550-3560
30. McKenzie RC, Szepietowski J. Cutaneous leukemia inhibitory factor and its potential role in the development of skin tumors. Dermatol Surg 2004; 30: 279-290
31. Okamoto M, Hattori K, Oyasu R. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 1997; 72: 149-154
32. Yu CY, Wang L, Khaletskiy A, Farrar WL, Larner A, Colburn NH, Li JJ. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells. Oncogene 2002; 21: 3949-3960
33. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/ STAT-3 signaling pathway. Biochem Biophys Res Commun 2002; 290: 249-255
34. Wojciechowska-Lacka A, Matecka-Nowak M, Adamiak E, Lacki JK, Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 1996; 43: 155-158
35. Baumann H, Wang Y, Morella KK, Lai CF, Dams H, Hilton DJ, Hawley RG, Mackiewicz A. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol 1996; 157:284-290
36. Ault P, Kantarjian H, Welch MA, Giles F, Rios MB, Cortes J. Interleukin 11 May improve thrombocytopenia associated with imatinib mesylate therapy in chronic Myelogenous leukemia. Leuk Res 2004; 28: 613-618